Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DiabiLive is a digital diabetes management platform from Diabetic Live Wellness Inc., positioned around “real-time insights + personalized health guidance.” It brings together data from continuous glucose monitoring devices, traditional glucose meters, Bluetooth devices, and activity sources such as Google Fit to help users understand the relationship between blood glucose, exercise, nutrition, and long-term health. The website also describes it as a Class IIb Certified Medical Device, but does not specify the applicable region or provide a regulatory registration number.
The platform covers real-time glucose monitoring, intelligent insulin management, interactive health coaching, automated clinical reports, and predictive health analytics. Its AI-related claims mainly appear in references to “advanced algorithms” and “predictive analytics”: it can calculate insulin doses based on clinical protocols and real-time biometric data, identify glucose trends, and provide proactive alerts. However, the website does not disclose the specific models used, training data, clinical validation results, or safety boundaries, so it should not be understood as a fully automated medical decision-making system.
DiabiLive uses a monthly subscription model: Basic at $49/month, Clinical Pro at $99/month, Total Care at $149/month, and Healthcare Partner at $199/month. Lower-tier plans cover glucose tracking, a nutrition library, and progress reports; higher tiers add dose calculation, clinical data sharing, 24/7 digital health guidance, full device integration, and multi-user clinical dashboards. No free trial or free tier is shown, and the long-term cost for individual users is not low.
Its strengths are a fairly complete workflow: it supports daily self-management for patients while also accommodating follow-up visits and data review by doctors or care teams. Educational resources, nutrition and exercise recommendations, and reporting features can reduce the burden of long-term management. The main limitation is insufficient disclosure of key information: there is no clear statement on Chinese-language support, open APIs, payment methods, device compatibility lists, privacy compliance details, or algorithm accuracy and clinical outcome data. Its terms of service also state that the content does not constitute medical advice and cannot replace a doctor.
DiabiLive is suitable for people with diabetes who need continuous glucose monitoring and want to combine glucose data with lifestyle management. It may also fit health management organizations that need multi-patient reports and dashboards. Access from China is unknown; the website does not explain network availability in China, local payment options, Chinese-language customer support, or compatibility with domestic glucose meters. If used in China, users should carefully confirm device synchronization, payment, cross-border data handling, and workflows for doctor collaboration. Comparable products include MySugr, Glooko, One Drop, Dexcom Clarity, LibreView, and domestic diabetes management tools.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on diabilive.com official site.
diabilive.com is an Unknown AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach diabilive.com directly.